loader image
Friday, October 10, 2025
78.6 F
McAllen
- Advertisement -

Three Deadliest Risk Factors of a Common Liver Disease Identified in New Study 

Translate to Spanish or other 102 languages!

Patients with a chronic liver disease known as MASLD who have high blood pressure, pre-diabetes/diabetes or low HDL cholesterol at greatest risk. Image for illustration purposes
Patients with a chronic liver disease known as MASLD who have high blood pressure, pre-diabetes/diabetes or low HDL cholesterol at greatest risk. Image for illustration purposes
- Advertisement -

Newswise — LOS ANGELES  More than a third of the world’s population is affected by metabolic dysfunction-associated steatotic liver disease, or MASLD, the most common chronic liver disease in the world.  

MASLD occurs when fat builds up in the liver and is associated with one or more of five conditions: obesity, Type 2 diabetes, high blood pressure, high blood sugar and low HDL cholesterol, known as “good” cholesterol. These conditions are characterized as cardiometabolic risk factors because they affect the heart or metabolism.  

MASLD can lead to serious illness, such as advanced liver, heart and kidney disease, but little research has been done to examine if certain cardiometabolic risk factors for those with MASLD are more associated with death than others.  

- Advertisement -

The deadliest cardiometabolic risk factors  

Now, a new study from Keck Medicine of USC published in Clinical Gastroenterology and Hepatology reveals that three of the cardiometabolic risk factors carry the greatest risk of death for those with MASLD: high blood pressure, pre-diabetes or Type 2 diabetes, and low HDL, which raise the risk of death by 40%, 25% and 15%, respectively.  

These results were independent of how many or which combination of cardiometabolic risk factors patients had, and held steady despite individuals’ gender, sex, race or ethnicity.  

“MASLD is a complicated disease, and this study sheds new light on where doctors may want to focus their efforts when treating patients,” said Norah A. Terrault, MD, a hepatologist with Keck Medicine and a senior author of the study. “Knowing which aspects of MASLD might lead to poorer outcomes can help us offer patients the best possible care.”  

- Advertisement -

Researchers were especially surprised to discover that high blood pressure was associated with a higher chance of death than diabetes, said Matthew Dukewich, MD, PharmD, MS, a USC transplant hepatology fellow and lead author of the study. “Until now, it was commonly thought that diabetes was the most pressing health problem for MASLD patients, which is a key insight.” 

The study also found that obesity, the most common cardiometabolic risk factor of MASLD,  can substantially raise the risk of mortality depending on a patient’s body mass index (BMI), which is a formula used to estimate body fat percentage based on an individual’s height and weight. The higher a patient’s BMI, the higher the association with death. 

Additionally, the study adds to the growing body of research that patients with more cardiometabolic risk factors have poorer outcomes. The study found that the risk of death in MASLD patients increased by 15% for each additional cardiometabolic risk factor present. 

How the study was conducted  

Researchers used data from the National Health and Nutrition Examination Survey (NHANES), which collected health information about children and adults in the United States from 1988-2018, the most current year for which data was available for their study. Out of 134,515 participants 20 years or older, some 21,000 patients qualified as having MASLD.  

The study authors tracked all-cause mortality rates by individual cardiometabolic risk factors to reach their conclusions.  

Looking ahead, the study authors hope to conduct further studies examining patients’ genetic background, dietary habits and alcohol use in relation to MASLD outcomes to provide more comprehensive risk profiles. “The more we can understand about the drivers of the disease, the more we can identify those most in need of interventions and prioritize our resources for enhanced outcomes,” said Terrault.  

Liyun Yuan, MD, a transplant hepatologist with Keck Medicine, is also a study author. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Pharr Declares October 2025 as National Breast Cancer Awareness Month

The City of Pharr proudly supports Breast Cancer Awareness Month and remains committed to promoting education, prevention, and hope for a cure.

Microplastics in the Gut Tied to Patterns Seen in Colorectal Cancer

Microplastics are common and consist of tiny pieces of plastic that are 5 millimeters (mm) or less. Recent study results, which have not been published in a peer-reviewed journal yet, show that how microplastics may impact bacteria in the human gut.

DHR Health Brownsville’s Fall Fest and Health Fair, Oct. 25th

DHR Health Brownsville invites the community to take charge of their health and celebrate the season in a very healthy way with their first ever Fall Fest and Health Fair. The event is set to take place from 8 a.m. to noon on October 25, 2025 at the DHR Health Brownsville Hospital located at 4750 North Expressway 77 in Brownsville. The event is free and open to the public.  

Dr. David G. Alonzo Reaches 1,000th da Vinci Robotic-Assisted Cancer Surgery Milestone

DHR Health Urologic Oncologist, Dr. David G. Alonzo, has successfully performed his 1,000th da Vinci robotic-assisted surgical procedure for the treatment of urologic cancers
- Advertisement -
×